Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Completed 21Recruiting 7Unknown 4Withdrawn 2Terminated 2Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 31NIH 11INDUSTRY 4UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 362Thoracic 304Other solid neoplasm 265Lymphoid 245Breast 234Other hematologic neoplasm 173Genitourinary 153Gynecologic 135Tumor-Agnostic 106Dermatologic 92Head & Neck 84CNS 78Plasma cell 67Sarcoma 58Myeloid 31Endocrine 17Classical hematology 11NET 7Other 5Other neoplasm 4

Conditions

Advanced Malignant Neoplasm 3Hepatic Malignant Neoplasm Primary Non-Resectable 1

Interventions

Rifampin 1Itraconazole 1Injections 1Infusions, Intravenous 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Other neoplasm × Clear all
NCT06165822 2023-12-12

A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Unknown
40 enrolled
Other neoplasm

Advanced Malignant Neoplasm

NCT05867563 2023-07-10

Clinical Trial Evaluating the Safety of the TQB2103 for Injection

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Unknown
71 enrolled
Other neoplasm

Advanced Malignant Neoplasm

NCT05048160 2022-05-09

A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 1/2 Unknown
272 enrolled
Other neoplasm

Advanced Malignant Neoplasm

NCT03266042 2018-09-11

Registry Protocol- Melphalan Percutaneous Hepatic Perfusion for the Treatment of Unresectable Hepatic Malignancy

Delcath Systems Inc.

Unknown
200 enrolled
Other neoplasm

Hepatic Malignant Neoplasm Primary Non-Resectable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡